Treatment of severe persistent asthma with IL-6 receptor blockade

Research output: Contribution to journal › Research article › Contributed › peer-review

Contributors

  • Brittany Esty - , Harvard Medical School (HMS) (Author)
  • Hani Harb - , Boston Children's Hospital, Harvard Medical School (HMS) (Author)
  • Lisa M Bartnikas - , Harvard Medical School (HMS) (Author)
  • Louis M Charbonnier - , Harvard Medical School (HMS) (Author)
  • Amir H Massoud - , Harvard Medical School (HMS) (Author)
  • Carmen Leon-Astudillo - , Harvard Medical School (HMS) (Author)
  • Gary Visner - , Harvard Medical School (HMS) (Author)
  • Meera Subramaniam - , Harvard Medical School (HMS) (Author)
  • Wanda Phipatanakul - , Harvard Medical School (HMS) (Author)
  • Talal A Chatila - , Harvard Medical School (HMS) (Author)

Details

Original languageEnglish
Pages (from-to)1639-1642.e4
JournalJournal of Allergy and Clinical Immunology: In Practice
Volume7
Issue number5
Publication statusPublished - 2019
Peer-reviewedYes
Externally publishedYes

External IDs

PubMedCentral PMC6511285
Scopus 85063728752
ORCID /0000-0001-8218-2538/work/173988785

Keywords

Keywords

  • Acetates/therapeutic use, Adrenal Cortex Hormones/therapeutic use, Anti-Asthmatic Agents/therapeutic use, Anti-Bacterial Agents/therapeutic use, Antibodies, Monoclonal, Humanized/therapeutic use, Asthma/drug therapy, Azithromycin/therapeutic use, Budesonide, Formoterol Fumarate Drug Combination/therapeutic use, Child, Child, Preschool, Cyclopropanes, Drug Resistance, Forced Expiratory Volume, Humans, Immunoglobulins, Intravenous/therapeutic use, Immunologic Factors/therapeutic use, Interleukin-4 Receptor alpha Subunit/genetics, Male, Prednisolone/therapeutic use, Quinolines/therapeutic use, Severity of Illness Index, Sulfides, Theophylline/therapeutic use, Vital Capacity